$0.30
0.00 (-1.40%)
Open$0.30
Previous Close$0.30
Day High$0.31
Day Low$0.29
52W High$2.75
52W Low$0.23
Volume—
Avg Volume1.09M
Market Cap4.69M
P/E Ratio—
EPS$-3.34
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+12,704.2% upside
Current
$0.30
$0.30
Target
$37.99
$37.99
$25.94
$37.99 avg
$62.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 30.87M | 24.46M | 257.5K |
| Net Income | -61,992,833 | -44,206,916 | -16,876 |
| Profit Margin | -200.8% | -190.8% | -6.6% |
| EBITDA | -62,349,615 | -46,931,411 | -21,131 |
| Free Cash Flow | — | — | -13,268 |
| Rev Growth | +26.2% | +26.2% | +2.0% |
| Debt/Equity | 0.08 | 0.08 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $254.31 | +0.38% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $360.55 | +0.62% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.33 | -1.21% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $499.65 | +1.69% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $631.81 | -0.17% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.52 | +0.74% | 69.3 | 39.97B |